Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.




dWMS is Renew’s long-read, Oxford Nanopore–based whole-genome sequencing service for integrated genomic and epigenomic profiling. By sequencing native DNA directly, dWMS captures genome-wide methylation without bisulfite conversion while preserving full genomic context. In the human genome, this corresponds to coverage of more than 27 million CpG sites. With scalable coverage, dWMS supports unbiased discovery, biomarker development, translational research, and clinical assay development.
dWMS uses long-read Oxford Nanopore sequencing to directly measure methylation from native DNA, eliminating bisulfite conversion and associated bias. It enables base-resolution detection of multiple DNA modifications and captures ~30× more CpG sites and ~2× more CpG islands than arrays for comprehensive, genome-wide methylation profiling.
Renew converts raw nanopore data into CH3 files, an analysis-ready format that preserves native-read information. These files can be analyzed by Renew or by clients using ModSeqR, our R package for accessible summary, visualization, and interpretation of whole genome methylation data. For projects with more specialized requirements, Renew also offers custom bioinformatics pipeline development tailored to specific research and clinical objectives.
Sample requirements vary by sample type and project goals. dWMS has been validated across 15+ sample types, including human tissue, whole blood, saliva, and plant and animal samples. Coverage can be tailored (from ~5× to 50×+) depending on whether your project's goals.
To submit samples or confirm requirements, contact Renew to connect with our technical team.
Getting started is easy. Contact the Renew team to discuss your project goals in a one-on-one consultation. Our experts in genomics, epigenomics, and long-read sequencing will help design a tailored workflow and guide your project from study design through data delivery.
A whole-genome dWMS approach provides an unbiased, comprehensive view of DNA methylation across the entire genome, including regulatory, repetitive, and noncoding regions that targeted methods and arrays often miss. By capturing methylation alongside sequence variation and structural context in a single assay, dWMS supports biological insight, biomarker discovery, and scalable translational and clinical study designs.